SG11202001551YA - Dynamic human heavy chain antibody libraries - Google Patents

Dynamic human heavy chain antibody libraries

Info

Publication number
SG11202001551YA
SG11202001551YA SG11202001551YA SG11202001551YA SG11202001551YA SG 11202001551Y A SG11202001551Y A SG 11202001551YA SG 11202001551Y A SG11202001551Y A SG 11202001551YA SG 11202001551Y A SG11202001551Y A SG 11202001551YA SG 11202001551Y A SG11202001551Y A SG 11202001551YA
Authority
SG
Singapore
Prior art keywords
heavy chain
chain antibody
human heavy
antibody libraries
dynamic human
Prior art date
Application number
SG11202001551YA
Inventor
Yan Li
Fangyong Du
Peter Peizhi Luo
Original Assignee
Adagene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adagene Inc filed Critical Adagene Inc
Publication of SG11202001551YA publication Critical patent/SG11202001551YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/04Methods of creating libraries, e.g. combinatorial synthesis using dynamic combinatorial chemistry techniques
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/005Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51Complete heavy chain or Fd fragment, i.e. VH + CH1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
SG11202001551YA 2017-08-21 2017-08-21 Dynamic human heavy chain antibody libraries SG11202001551YA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2017/098299 WO2019036842A1 (en) 2017-08-21 2017-08-21 Dynamic human heavy chain antibody libraries

Publications (1)

Publication Number Publication Date
SG11202001551YA true SG11202001551YA (en) 2020-03-30

Family

ID=65438261

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202001551YA SG11202001551YA (en) 2017-08-21 2017-08-21 Dynamic human heavy chain antibody libraries

Country Status (11)

Country Link
US (1) US11578426B2 (en)
EP (1) EP3673101A4 (en)
JP (2) JP2020537632A (en)
KR (1) KR20200038996A (en)
CN (1) CN111279024A (en)
AU (1) AU2017428737B2 (en)
BR (1) BR112020003622A2 (en)
CA (1) CA3072143A1 (en)
IL (1) IL272696A (en)
SG (1) SG11202001551YA (en)
WO (1) WO2019036842A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020003459A2 (en) 2017-08-21 2020-08-25 Adagene Inc. libraries, non-human animal, phage, antibody light chain, antibodies, methods for preparing a library, for producing an antibody library and for generating a bispecific antibody and kit
CN111511762A (en) 2017-08-21 2020-08-07 天演药业公司 anti-CD137 molecules and uses thereof
WO2019148445A1 (en) 2018-02-02 2019-08-08 Adagene Inc. Precision/context-dependent activatable antibodies, and methods of making and using the same
WO2019148444A1 (en) 2018-02-02 2019-08-08 Adagene Inc. Anti-ctla4 antibodies and methods of making and using the same
WO2021225954A1 (en) * 2020-05-04 2021-11-11 The Regents Of The University Of California Inhibiting anti-enpp1 antibodies
WO2023193239A1 (en) * 2022-04-08 2023-10-12 Peter Peizhi Luo Anti-cd28 antibodies and methods of use thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
EP1690935A3 (en) 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
DE4002897A1 (en) * 1990-02-01 1991-08-08 Behringwerke Ag Synthetic human antibody library
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
ES2246502T3 (en) 1990-08-29 2006-02-16 Genpharm International, Inc. TRANSGENIC NON-HUMAN ANIMALS ABLE TO PRODUCE HETEROLOGICAL ANTIBODIES.
US7018809B1 (en) 1991-09-19 2006-03-28 Genentech, Inc. Expression of functional antibody fragments
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
US5866344A (en) 1991-11-15 1999-02-02 Board Of Regents, The University Of Texas System Antibody selection methods using cell surface expressed libraries
US20030036092A1 (en) 1991-11-15 2003-02-20 Board Of Regents, The University Of Texas System Directed evolution of enzymes and antibodies
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
EP1709970A1 (en) 1995-04-27 2006-10-11 Abgenix, Inc. Human antibodies against EGFR, derived from immunized xenomice
CA2219486A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
CA2722378C (en) 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
ES2248127T3 (en) 1999-10-04 2006-03-16 Medicago Inc. METHOD FOR REGULATING THE TRANSCRIPTION OF FOREIGN GENES IN THE PRESENCE OF NIGTROGEN.
DE60224720D1 (en) * 2001-11-22 2008-03-06 Univ Keio Re
US7785903B2 (en) 2004-04-09 2010-08-31 Genentech, Inc. Variable domain library and uses
EP1879921B1 (en) 2005-05-12 2011-04-27 Crucell Holland B.V. Host cell specific binding molecules capable of neutralizing viruses and uses thereof
ES2577292T3 (en) 2005-11-07 2016-07-14 Genentech, Inc. Binding polypeptides with diversified VH / VL hypervariable sequences and consensus
WO2009120922A2 (en) 2008-03-27 2009-10-01 Zymogenetics, Inc. Compositions and methods for inhibiting pdgfrbeta and vegf-a
US9354228B2 (en) * 2010-07-16 2016-05-31 Adimab, Llc Antibody libraries
ES2537207T3 (en) 2010-08-16 2015-06-03 Novimmune S.A. Methods for the generation of multispecific and multivalent antibodies
CA2905529C (en) 2013-03-14 2023-03-14 Adagene Inc. An integrated system for library construction, affinity binder screening and expression thereof
CN103603057B (en) 2013-07-03 2016-01-06 深圳大学 Based on can the antibody screening in infecting virus particle type heavy chain of antibody storehouse/light chain storehouse and preparation method
US20170306039A1 (en) * 2014-10-22 2017-10-26 Crescendo Biologics Limited Human vh domain scaffolds
US11078286B2 (en) 2015-09-20 2021-08-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use
BR112020003459A2 (en) 2017-08-21 2020-08-25 Adagene Inc. libraries, non-human animal, phage, antibody light chain, antibodies, methods for preparing a library, for producing an antibody library and for generating a bispecific antibody and kit

Also Published As

Publication number Publication date
BR112020003622A2 (en) 2020-09-01
WO2019036842A1 (en) 2019-02-28
AU2017428737A8 (en) 2020-03-12
KR20200038996A (en) 2020-04-14
CA3072143A1 (en) 2019-02-28
JP2020537632A (en) 2020-12-24
EP3673101A1 (en) 2020-07-01
AU2017428737A1 (en) 2020-03-05
US11578426B2 (en) 2023-02-14
IL272696A (en) 2020-04-30
JP2023025026A (en) 2023-02-21
US20200248336A1 (en) 2020-08-06
EP3673101A4 (en) 2021-03-24
CN111279024A (en) 2020-06-12
AU2017428737B2 (en) 2024-02-15

Similar Documents

Publication Publication Date Title
IL268517A (en) Anti-tigit antibodies
IL268620A (en) Anti-lag3 antibodies
IL272227A (en) Anti-tigit antibodies
IL267797A (en) Anti-gpc3 antibody
IL273411A (en) Anti-pd-l1 antibody and uses thereof
IL272696A (en) Dynamic human heavy chain antibody libraries
GB201709808D0 (en) Antibodies
SG10201913206RA (en) Antibodies comprising modified heavy constant regions
IL268112A (en) Anti-tgf-beta antibodies and their use
HUE059237T2 (en) Garp-tgf-beta antibodies
SG11202004172UA (en) Il2rbeta/common gamma chain antibodies
IL272699A (en) Dynamic human antibody light chain libraries
IL270698A (en) Canine antibody libraries
GB201720970D0 (en) Antibodies
IL273529A (en) Anti-pacap antibody
IL275187A (en) Anti-alpha-synuclein antibodies
IL271818A (en) Single chain vh and heavy chain antibodies
IL272266A (en) Anti-cd147 antibody
IL271067A (en) Anti-trkb antibodies
IL273351A (en) Antibody variants
RS61883B1 (en) Antibody variants
IL274202A (en) Anti-glyco-muc1 antibodies and their uses
IL272951A (en) Antibody variants
GB201709592D0 (en) Antibody
GB201717006D0 (en) Anti-OPG antibodies